TY  - JOUR

T1  - Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

JO  - Bone Marrow Transplantation

UR  - http://dx.doi.org/10.1038/s41409-023-02150-w

PY  - 2023/12/02

AU  - Duque-Afonso J

AU  - Finke J

AU  - Ngoya M

AU  - Galimard J-E

AU  - Craddock C

AU  - Raj K

AU  - Bloor A

AU  - Nicholson E

AU  - Eder M

AU  - Kim O

AU  - Valerius T et al

ED  - 

DO  - DOI: 10.1038/s41409-023-02150-w

PB  - Springer Science and Business Media LLC

Y2  - 2024/12/22

ER  -